Surgery and attention functions in glioma brain patients - Payesh (Health Monitor)
Wed, Apr 24, 2024
OPEN ACCESS
Volume 18, Issue 1 (January-February 2019)                   Payesh 2019, 18(1): 37-44 | Back to browse issues page

Ethics code: EE/96.24.3.7789//sscu.ac.ir

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Basak Nejad S, Arshadi N, Mehrabizadeh Honarmand M, Ganji N. Surgery and attention functions in glioma brain patients. Payesh 2019; 18 (1) :37-44
URL: http://payeshjournal.ir/article-1-972-en.html
1- Shahid Chamran University of Ahvaz, Ahvaz, Iran
Abstract:   (3706 Views)
Objective (s): The present study aimed to determine the effect of surgery on attention functions in glioma brain patients.
Methods: The statistical population of this study was all individuals aged 18 to 45 years old, referred to neurosurgery department of hospitals in Tehran, Iran in 2016 to 2018 for Glioma surgery. A total of 30 glioma brain patients entered into the study. Continuous attention by continuous performance tests, divided attention by trial making test and selective attention by Stroop test was measured. To evaluate the effect of surgery on research variables t-test, repeated measures and multivariate analyses.
Results: The statistical analyses showed that surgery increased the mean scores of attentional functions (all three types of attentions) in patients (P <0.001).
Conclusion: The present study showed that surgery improved attentional functions in patients with glioma brain tumors.
Full-Text [PDF 727 kb]   (1487 Downloads)    
type of study: Descriptive |
Accepted: 2019/02/17 | ePublished ahead of print: 2019/02/23 | Published: 2019/04/16

References
1. O'Shaughnessy J A, Wittes R E, Burke G, Friedman M A, Johnson J R, Niederhuber J E, et al. Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. Journal of Clinical Oncology 1991; 12: 2225-2232 [DOI:10.1200/JCO.1991.9.12.2225]
2. Emily R, David A R, April D C, James E H, Whitney E H, Miranda W, et al. Exercise Behavior, Functional Capacity and Survival in Adults with Malignant Recurrent Glioma. Journal of Clinical Oncology 2011;3: 2918-2923
3. Brown E S, Chandler P A. Mood and Cognitive Changes During Systemic Corticosteroid Therapy. Prim Care Community Psychiatry 2001; 3: 17-21 [DOI:10.4088/PCC.v03n0104]
4. Meyers C A, Cantor S B. Neuropsychological assessment and treatment of patients with malignant brain tumors, In: Prigatano G P, Pliskin N H. (Eds) Clinical neuropsychology and Cost Outcome Research, A beginning. 1st Edition, Psychology Press, Inc: New York, 2003
5. Taphoorn M J, Klein M. Cognitive deficits in adult patients with brain tumors. Lancet Neurology 2004; 3: 159-168 [DOI:10.1016/S1474-4422(04)00680-5]
6. Olson R A, Iverson G L, Carolan H, Parkinson M, Brooks,B L, McKenzie M. Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life. Journal of Neurooncology 2011; 105: 337-344 [DOI:10.1007/s11060-011-0595-4]
7. Papagno C, Casarotti A, Comi A, Gallucci M, Riva M, Bello L. Measuring clinical outcomes in neuro-oncology. A battery to evaluate low-grade gliomas (LGG). Journal of Neurooncology 2012; 108: 269-275 [DOI:10.1007/s11060-012-0824-5]
8. Papazoglou A, King T Z, Morris R D, Krawiecki N S. Cognitive predictors of adaptive functioning vary according to pediatric brain tumor location. Developmental Neuropsychology 2008; 33: 505-520 [DOI:10.1080/87565640802101490]
9. Riva D, Giorgi C. The cerebellum contributes to higher functions during development: Evidence from a series of children surgically treated for posterior fossa tumors. Brain 2000; 123: 1051-1061 [DOI:10.1093/brain/123.5.1051]
10. Riva D, Pantaleoni C, Milani N, Belani F F. Impairment of neuropsychological functions in children with medulloblastomas and astrocytomas in the posterior fossa. Child's Nervous System 1989; 5: 107-110 [DOI:10.1007/BF00571120]
11. Steinlin M, Imfeld S, Zulauf P, Bolthauser E, Lovblad K O, Luthy A R, et al. Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood. Brain 2003; 126: 1998-2008 [DOI:10.1093/brain/awg195]
12. Akshoomoff N A, Courchesne E. A new role for the cerebellum in cognitive operations. Behavioral Neuroscience 1992; 106: 731-73 [DOI:10.1037/0735-7044.106.5.731]
13. Karatekin C, Lazareff J A, Asamow R F. Relevance of the cerebellar hemispheres for executive functions. Pediatric Neurology 2000; 22: 106-112 [DOI:10.1016/S0887-8994(99)00128-9]
14. Mandolesi L, Leggio M G, Graziano A, Neri P, Petrosini L. Cerebellar contribution to spatial event processing: Involvement in procedural and working memory components. European Journal of Neuro science 2001; 14: 2011-2022 [DOI:10.1046/j.0953-816x.2001.01819.x]
15. Homack S, Riccio C A. A meta - analysis of the sensitivity and specificity of the stroop color and word test with children. Clinical Neuropsychology 2003; 10: 725-743 [DOI:10.1016/j.acn.2003.09.003]
16. Rosvold H. E, Mirsky A F, Sarason I, Bransome E D, Beck L H. A continuous performance test of brain damage. Journal of Counsulting Psychology 1956;20: 343-350 [DOI:10.1037/h0043220]
17. Mahmoud Aliloo M, Hamidi S, Shirvani A. Comparison of executive function and sustained attention in students with obsessive-compulsive, high schizotypal and overlapping symptoms with the normal group. Journal of Research in Behavioral Science 2011; 9: 216-221
18. Tombaugh T N. Trail Making Test A and B: Normative data stratified by age and education. Archives of Clinical Neuropsychology 2004; 19: 203-214 [DOI:10.1016/S0887-6177(03)00039-8]
19. Reitan R M. Validity of the Trail Making test as an indicator of organic brain damage. Perceptual and Motor Skills 1958; 8: 271-276 [DOI:10.2466/pms.1958.8.3.271]
20. Mazhari Sh, Pourrahimi A M, Parvaresh N, Eslami Shahrbabaki M, Yazdani M. Relation of Visual and Representational Pseudoneglect and Attention Deficit in Patients with Schizophrenia. Iranian Journal of Psychiatry and Clinical Psychology 2015;21: 225-235
21. Chan R C, Chen E Y, Law C W. Specific executive dysfunction in patients with first-episode medication-naive schizophrenia. Schizophrenia Research 2006; 82: 51-64 [DOI:10.1016/j.schres.2005.09.020]
22. Bozikas V P, Kosmidis M H., Kiosseoglou G, Karavatos A. Neuropsychological profile of cognitively impaired patients with schizophrenia. Comprehensive Psychiatry 2006; 47:136-143 [DOI:10.1016/j.comppsych.2005.05.002]
23. Karimi Aliabad M, Kafi S M, Farrahi H. Study of Executive Functions in Bipolar Disorders Patients. Advances in Cognitive Science 2010; 12: 29-39
24. Ghadiri F, Jazayeri A, Ashaeri A, Ghazi Tabatabaei M. Deficit in Executive Functioning in Patients With Schizo-Obsessive Disorder. Journal of Advances in Cognitive Sciences 2001; 8: 11-24
25. Dhandapani M, Gupta S, Mohanty M, Gupta S K., Dhandapani S. Trends in cognitive dysfunction following surgery for intracranial tumors. Surgical Neurology International 2016; 7: 190-195 [DOI:10.4103/2152-7806.179229]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and Permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb